Follow-up study on symptom distress in esophageal cancer patients undergoing repeated dilation

doi:10.12998/wjcc.v8.i16.3503

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3862)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-7) series.

Item

Count

PDF

207

WORD

169

HTML

1849

Figures (1-2)

270

Tables (1-7)

187

Sum=2682

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

358

Download

822

Sum=1180

Aug 26, 2020 (publication date) through May 4, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Cases. Aug 26, 2020; 8(16): 3503-3514
Published online Aug 26, 2020. doi: 10.12998/wjcc.v8.i16.3503

Table 1 Dilatation times in esophageal carcinoma patients repeatedly undergoing dilation for esophageal stenosis

	Achieved marked effect		Cumulative percentage	Did not achieve significant results
	n	Percentage (%)	Cumulative percentage	n	Percentage (%)
1 time	3	2.86	2.86	102	97.14
2 times	6	5.88	8.57	96	94.12
3 times	43	44.79	49.52	53	55.21
4 times	5	9.43	54.29	48	90.57
5 times	18	37.50	71.43	30	62.50
6 times	17	56.67	87.62	13	43.33

Table 2 Dilatation effect in esophageal carcinoma patients repeatedly undergoing dilation for esophageal stenosis

	1^st time (n = 105)	2^nd time (n = 102)	3^rd time (n = 96)	4^th time (n = 53)	5^th time (n = 48)	6^th time (n = 30)	7^th time (n = 13)	F/P value
R1 (mm)	5.16 ± 1.67	5.65 ± 0.99	6.37 ± 0.67	6.99 ± 1.18	7.27 ± 2.10	7.85 ± 2.74	8.21 ± 3.41	34.71/0.01^a
R2 (mm)	12.06 ± 2.92	12.27 ± 2.13	12.24 ± 1.69	12.62 ± 1.44	12.65 ± 2.39	13.27 ± 1.63	13.97 ± 2.11	16.95/0.00^a
R2-R1 (mm)	6.90 ± 1.03	6.62 ± 0.99	5.87 ± 1.54	5.63 ± 0.89	5.38 ± 1.41	5.42 ± 1.10	5.76 ± 0.84	3.29/0.00^a

^aP< 0.05.

Table 3 Symptom distress score (mean ± SD) of esophageal cancer patients who underwent repeated dilation for esophageal stenosis

	After the 1^st dilation (n = 105)	After the 2^nd dilation (n = 102)	After the 3^rd dilation (n = 96)	After the 4^th dilation (n = 53)	After the 5^th dilation (n = 48)	After the 6^th dilation (n = 30)	After the 7^th dilation (n = 13)	F/P value
Total score	185.49 ± 15.04	190.62 ± 14.83	189.11 ± 12.76	191.37 ± 14.20	193.55 ± 12.37	192.17 ± 15.10	194.04 ± 11.21	38.97/0.00^a
Symptom dimension	106.37 ± 8.79	111.08 ± 5.99	108.39 ± 4.11	110.35 ± 8.37	114.70 ± 6.81	110.24 ± 7.28	112.33 ± 9.10	14.24/0.00^a
Distress dimension	79.12 ± 2.66	79.54 ± 1.09	80.72 ± 1.37	81.02 ± 1.57	78.85 ± 1.98	81.93 ± 2.19	81.71 ± 6.68	17.64/0.00^a

^aP< 0.05.

Table 4 Symptom incidence and item score in esophageal carcinoma patients repeatedly undergoing dilation for esophageal stenosis

After the 1^st dilation (n = 105)			After the 2^nd dilation (n = 102)			After the 3^rd dilation (n = 96)			After the 4^th dilation (n = 53)			After the 5^th dilation (n = 48)			After the 6^th dilation (n = 30)			After the 7^th dilation (n = 13)
Item	%	mean ± SD	Item	%	mean ± SD	Item	%	mean ± SD	Item	%	mean ± SD	Item	%	mean ± SD	Item	%	mean ± SD	Item	%	mean ± SD
Dysphagia	63.2	6.4 ± 1.8	Dysphagia	58.9	6.2 ± 1.6	Dysphagia	69.1	6.7 ± 2.4	Distress	78.4	7.3 ± 2.6	Sadness	77.4	7.5 ± 3.1	Cough	78.1	7.3 ± 1.9	Sadness	79.6	7.9 ± 2.8
Pain	61.1	5.8 ± 2.3	Cough	56.6	6.1 ± 2.3	Weight loss	69.3	7.1 ± 1.8	Dysphagia	70.6	6.9 ± 3.1	Cough	73.9	6.6 ± 2.4	Sadness	77.5	7.3 ± 2.6	Fatigue	70	7.1 ± 1.7
Distress	57.3	6.1 ± 2.1	Pain	51.2	6.6 ± 1.4	Pain	67.9	6.8 ± 2.1	Fatigue	68.3	7.6 ± 2.2	Weight loss	70.1	7.1 ± 3.6	Fatigue	73.1	7.6 ± 2.7	Weight loss	69.5	6.9 ± 2.4

Table 5 Distress incidence and item score in esophageal carcinoma patients repeatedly undergoing dilation for esophageal stenosis

After the 1^st dilation (n = 105)			After the 2^nd dilation (n = 102)			After the 3^rd dilation (n = 96)			After the 4^th dilation (n = 53)			After the 5^th dilation (n = 48)			After the 6^th dilation (n = 30)			After the 7^th dilation (n = 13)
Item	%	mean ± SD	Item	%	mean ± SD	Item	%	mean ± SD	Item	%	mean ± SD	Item	%	mean ± SD	Item	%	mean ± SD	Item	%	mean ± SD
Work	49.3	4.7 ± 1.1	Work	56.7	4.8 ± 1.4	Emotion	56.2	4.7 ± 2.3	Emotion	57.3	5.1 ± 2.4	Life fun	49.6	4.7 ± 2.2	Life fun	51.4	5.2 ± 3.0	General activities	54.8	5.2 ± 2.4
Emotion	49	4.2 ± 1.2	Emotion	52.5	4.6 ± 2.2	General activities	40.6	4.2 ± 1.6	Life fun	40.7	4.5 ± 1.8	2 Emotion	48.1	4.9 ± 1.3	General activities	37.2	5.0 ± 2.9	Emotion	43.7	5.3 ± 1.7
General activities	32.1	3.8 ± 0.9	Life fun	50.9	3.9 ± 1.7	Life fun	37.3	4.1 ± 2.0	General activities	40.7	4.1 ± 2.3	3 General activities	31.7	4.9 ± 2.4	Emotion	37	4.9 ± 1.8	Life fun	42.9	3.9 ± 1.1

Table 6 Correlation between symptom distress and dilatation effect in esophageal carcinoma patients repeatedly undergoing dilation for esophageal stenosis (r)

	Symptom distress after the 1^st dilation (n = 105)	Symptom distress after the 2^nd dilation (n = 102)	Symptom distress after the 3^rd dilation (n = 96)	Symptom distress after the 4^th dilation (n = 53)	Symptom distress after the 5^th dilation (n = 48)	Symptom distress after the 6^th dilation (n = 30)	Symptom distress after the 7^th dilation (n = 13)
R2-R1	-0.356^a	-0.332^a	-0.665^a	-0.157^a	-0.675^a	-0.293^b	-0.273^a
R2	-0.185^a	-0.257^a	-0.392^a	-0.366^a	-0.119	-0.665^a	-0.227^a

^aP < 0.05.

^bP < 0.01.

Table 7 Correlation between symptom distress and severity of esophageal restenosis in esophageal carcinoma patients repeatedly undergoing dilation for esophageal stenosis (r)

	Symptom distress after the 1^st dilation (n = 105)	Symptom distress after the 2^nd dilation (n = 102)	Symptom distress after the 3^rd dilation (n = 96)	Symptom distress after the 4^th dilation (n = 53)	Symptom distress after the 5^th dilation (n = 48)	Symptom distress after the 6^th dilation (n = 30)
R12	0.304^b	-0.306^a	-0.311^b	-0.565^b	-0.198	-0.278

^aP < 0.05.

^bP < 0.01.

Citation: Liu L, Liu QW, Wu XD, Liu SY, Cao HJ, Hong YT, Qin HY. Follow-up study on symptom distress in esophageal cancer patients undergoing repeated dilation. World J Clin Cases 2020; 8(16): 3503-3514
URL: https://www.wjgnet.com/2307-8960/full/v8/i16/3503.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i16.3503